There is no legal retail version of CJC-1295 or ipamorelin. Neither is FDA-approved, so the only legitimate source is a licensed prescriber whose compounding pharmacy dispenses after a baseline IGF-1. The rest of the search results are research-chem sites that skip that route by design.
The honest answer to where to buy CJC-1295 and ipamorelin is narrower than the search results suggest. The only legitimate route is a prescription from a licensed clinician, filled by a compounding pharmacy that draws a baseline IGF-1 first. Both peptides are compounded preparations, not FDA-approved drugs, so there is no over-the-counter or retail version [2][3]. Everything else, the research-chem sites and the vials sold for research use only, sits outside that route by design.
- The only legitimate source is a licensed prescriber whose pharmacy dispenses after a baseline IGF-1
- Neither CJC-1295 nor ipamorelin is FDA-approved; both are dispensed only as compounded preparations [2][3]
- A legitimate compounded source uses a 503A or 503B pharmacy meeting USP 797 sterility standards
- Sites selling vials labeled for research use only or not for human consumption are the pattern to avoid
- A program that sets a dose without drawing a baseline IGF-1 has skipped the step that makes it measurable
- FDA has identified serious adverse events for CJC-1295 and flags ipamorelin as a compounding safety risk; both are prohibited in sport [2][4]
The Only Legitimate Route Is a Prescription
CJC-1295 and ipamorelin are prescription-only compounded peptides. A licensed clinician evaluates you, orders labs, and writes a prescription that a compounding pharmacy fills. There is no legal retail channel, because neither peptide has an FDA-approved product a pharmacy could stock off the shelf [2][3]. A telehealth clinic that runs this process is the accessible version of it.
The distinction that matters is compounding versus research chemicals. A compounding pharmacy operates under state and federal oversight and dispenses to a named patient against a prescription. A research-chem site ships a vial to anyone with a credit card and disclaims human use to sidestep that oversight. Same molecule on the label, a different chain of custody and accountability.
What a Legitimate Compounded Source Requires
A source worth buying from asks for more than payment. It runs the clinical steps that make the peptide measurable and safe to dose. If a seller skips these, that absence is the answer.
- A 503A or 503B compounding pharmacy. 503B is the higher regulatory standard, registered with FDA and inspected as an outsourcing facility
- USP 797 sterility compliance for the sterile injectable it is preparing
- A baseline IGF-1 draw before the first prescription, the number every later dose is judged against
- A licensed prescribing physician who reviews your labs and history, not a checkout form
- A Certificate of Analysis on request, confirming identity and purity of the compounded preparation
- A 90-day IGF-1 retest built into the protocol rather than left as an afterthought
Ask whether a baseline IGF-1 is required before the first vial ships. A legitimate source treats that draw as non-negotiable, because it is the only way to tell whether a dose is working or pushing IGF-1 above the age-adjusted range. A source that will ship without it has told you what it is.
The Research-Chemical Trap
Most of the search results for buying these peptides lead to research-chem sites, and their design is consistent. They sell vials labeled for research use only or not for human consumption, a legal disclaimer that lets them skip the prescription and the pharmacy oversight. The disclaimer is not a formality. It means no clinician evaluated you, no pharmacy stands behind the sterility, and no one drew a baseline.
The product itself is unverified. Independent testing of gray-market peptides has repeatedly found underdosed, mislabeled, or contaminated vials, because nothing in that supply chain ties a Certificate of Analysis to your purchase. FDA lists both peptides among substances it flags for compounding safety, citing serious adverse events for CJC-1295 and immunogenicity risk for ipamorelin [2]. In October 2024 an FDA advisory committee voted 0 in favor and 12 against permitting ipamorelin for compounding [3].
Red Flags at the Point of Sale
- Vials described as research chemicals, or any not for human consumption labeling
- No prescription and no lab work required before purchase
- A fixed dose sold identically to every buyer, a marketing number rather than a clinical one
- Pricing revealed only after a mandatory consultation call, a consistent red flag
- No named 503A or 503B pharmacy, and no Certificate of Analysis on request
- Claims of FDA approval for either peptide, which do not exist [2][3]
What It Costs and Why
Compounded peptide pricing runs on the prescription model, not a retail sticker. The monthly cost reflects the pharmacy's compounding, the clinician's oversight, and the labs, which is why a legitimate program costs more than a research-chem vial. The gap is the oversight you are paying for. A price far below the clinical range usually signals a source that removed the parts that cost money: the prescriber, the pharmacy standard, and the baseline draw.
Compare programs on what the price includes, not the headline number. A protocol that bundles the baseline IGF-1, the prescriber review, and the 90-day retest is buying you the data that tells you whether to continue. One that quotes only the vial has priced out the clinical layer that makes the peptide worth taking.
Questions to Ask Before You Buy
- Is a baseline IGF-1 required before the first prescription ships?
- Which pharmacy compounds it, and is it 503A or 503B registered?
- Does a licensed physician review my labs, or is this a checkout form?
- Is a Certificate of Analysis available for the batch?
- Is a 90-day IGF-1 retest part of the protocol?
- Which form of CJC-1295 is dispensed, with DAC or without, since the dosing schedule depends on it [1]?
The Honest Verdict
Where to buy CJC-1295 and ipamorelin has one honest answer and a field of wrong ones. The right route is a licensed telehealth clinic or prescriber whose compounding pharmacy draws a baseline IGF-1, dispenses under 503A or 503B standards, and builds in a 90-day retest. That path costs more than a research-chem vial because it includes the oversight that makes the peptide measurable and accountable.
The vials sold for research use only are cheaper for a reason: they removed the prescriber, the pharmacy standard, and the labs. Neither peptide is FDA-approved [2][3], so the compounding route is the ceiling on legitimacy, not a shortcut around it. Start from a baseline IGF-1, confirm which form of CJC-1295 you are getting, and treat any source that will ship without a lab draw as the red flag it is.
The line between a compounded prescription and a research-chem vial is the baseline IGF-1 and the licensed prescriber behind it. SystemLabs tests IGF-1 before prescribing and formulates CJC-1295 and ipamorelin on clinical indication through a compounding pharmacy, which is the route this whole guide points to.
Frequently Asked Questions
Where can you legally buy CJC-1295 and ipamorelin?
Only through a licensed clinician who prescribes it, filled by a 503A or 503B compounding pharmacy after a baseline IGF-1. Neither peptide is FDA-approved, so there is no legal retail or over-the-counter version [2][3]. Telehealth clinics that run labs and prescribe are the accessible form of that route.
Can you buy CJC-1295 and ipamorelin without a prescription?
The sites that sell it without a prescription do so by labeling the vials for research use only or not for human consumption, which sidesteps pharmacy oversight rather than satisfying it. That is not a legal consumer purchase; it is a gray-market research-chem sale with no clinician, no baseline lab, and no Certificate of Analysis tied to your vial.
Is it safe to buy peptides from a research-chem website?
No. Those vials carry no prescription, no 503A or 503B pharmacy standing behind their sterility, and no baseline IGF-1. Independent testing of gray-market peptides has repeatedly found underdosed, mislabeled, or contaminated product, and FDA flags both peptides for compounding safety risks including serious adverse events for CJC-1295 [2].
What makes a compounding pharmacy legitimate?
A legitimate compounding pharmacy is registered as 503A or 503B, meets USP 797 sterility standards for the injectable it prepares, and dispenses only against a prescription for a named patient. 503B is the higher standard, registered with FDA and inspected as an outsourcing facility. A Certificate of Analysis should be available on request.
How much does CJC-1295 and ipamorelin cost through a clinic?
Clinic pricing reflects the prescriber's oversight, the compounding pharmacy, and the labs, so it runs well above a research-chem vial. Compare programs on what the price includes: a baseline IGF-1, a physician review, and a 90-day retest. A price far below the clinical range usually means a source that removed those steps.
Do I need lab work to buy CJC-1295 and ipamorelin?
A legitimate source requires a baseline IGF-1 before the first prescription and a retest at about 90 days [1]. That draw is the single most reliable filter for a real source, because it is the only way to judge whether a dose is working or overshooting. A seller who will ship without it has answered the question of what it is.
References
- Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults Journal of Clinical Endocrinology & Metabolism, 2006. PMID: 16352683. https://pubmed.ncbi.nlm.nih.gov/16352683/
- Certain bulk drug substances for use in compounding that may present significant safety risks FDA.gov, Human Drug Compounding, 2026. Content current as of 04/22/2026. https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks
- Summary minutes of the Pharmacy Compounding Advisory Committee meeting, October 29, 2024 FDA Advisory Committee, 2024. PCAC summary minutes. https://www.fda.gov/media/185412/download
- The 2026 Prohibited List: International Standard, section S2.2.4 growth hormone releasing factors World Anti-Doping Agency, 2026. WADA 2026 Prohibited List. https://www.wada-ama.org/en/resources/2026-prohibited-list
